926922-41-0 Usage
Uses
Used in Organic Synthesis:
Tert-butyl 4-bromo-5-methyl-1H-indazole-1-carboxylate is used as a building block in organic synthesis for the creation of various bioactive molecules. Its unique structure allows for the development of new compounds with potential applications in different fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, tert-butyl 4-bromo-5-methyl-1H-indazole-1-carboxylate is used as an intermediate in the preparation of medicinal compounds. Its potential therapeutic applications are being studied, making it a valuable asset in drug discovery and development.
Used in Medicinal Chemistry:
Tert-butyl 4-bromo-5-methyl-1H-indazole-1-carboxylate is employed in medicinal chemistry for the design and synthesis of new drugs. Its structural features enable the exploration of novel therapeutic agents with improved efficacy and selectivity.
Overall, tert-butyl 4-bromo-5-methyl-1H-indazole-1-carboxylate is a versatile and important compound in the fields of organic synthesis, pharmaceutical research, and medicinal chemistry, with its potential applications in the development of new bioactive molecules and therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 926922-41-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,6,9,2 and 2 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 926922-41:
(8*9)+(7*2)+(6*6)+(5*9)+(4*2)+(3*2)+(2*4)+(1*1)=190
190 % 10 = 0
So 926922-41-0 is a valid CAS Registry Number.
926922-41-0Relevant articles and documents
Novel N9-arenethenyl purines as potent dual Src/Abl tyrosine kinase inhibitors
Wang, Yihan,Shakespeare, William C.,Huang, Wei-Sheng,Sundaramoorthi, Raji,Lentini, Scott,Das, Sasmita,Liu, Shuangying,Banda, Geeta,Wen, David,Zhu, Xiaotian,Xu, Qihong,Keats, Jeffrey,Wang, Frank,Wardwell, Scott,Ning, Yaoyu,Snodgrass, Joseph T.,Broudy, Mark I.,Russian, Karin,Dalgarno, David,Clackson, Tim,Sawyer, Tomi K.
scheme or table, p. 4907 - 4912 (2009/05/30)
Novel N9-arenethenyl purines, optimized potent dual Src/Abl tyrosine kinase inhibitors, are described. The key structural feature is a trans vinyl linkage at N9 on the purine core which projects hydrophobic substituents into the sele
UNSATURATED HETEROCYCLIC DERIVATIVES
-
Page/Page column 43, (2008/06/13)
This invention relates to compounds of the general formula: in which the variable groups are as defined herein, and to their preparation and use.
